Providing independent clinical excellence since 2005
As cardiovascular medicine becomes better at predicting and preventing heart disease, cancer has emerged as the greater threat to long-term health. This article explores the evidence behind multi-cancer early detection blood tests and PSA screening, their real limitations, and why proactive cardiovascular clinics are leading this broader conversation.
As cardiovascular prevention advances, could emerging cancer detection technologies become the next frontier in proactive healthcare?
Insulin resistance often develops silently for years before diabetes or heart disease appears. Discover how modern metabolic assessment, including body composition, visceral fat analysis and targeted blood testing, can identify early risk, allowing personalised lifestyle and medical strategies to restore metabolic health, improve energy, and reduce long-term cardiovascular risk.
Men attending a heart clinic rarely come in with just one concern. Erectile dysfunction, prostate health and unexplained weight gain share biological pathways with cardiovascular disease. This article explores why one cardiology clinic built a dedicated men's health service, and what those links mean for patients and GPs.
Traditional upper limits for ALT (often ≤55 U/L in UK labs) were derived decades ago, before the epidemic of obesity and steatosis. Current evidence suggests these ranges are too high — and that values above 30 U/L may already indicate liver injury in people with metabolic risk. The British Society of Gastroenterology (BSG) guidelines emphasise that a result within the “normal range” may not be reassuring if the patient is metabolically high-risk
For much of modern cardiology, in its battle against coronary artery disease—one of mankind’s greatest threats—the “enemy” seemed clear. When I trained, the diagnostic armoury was focused on accurately identifying flow-limiting narrowing of one or more coronary arteries. Yet in the last decade, a profound paradigm shift has unsettled these foundations—and in some respects, turned them on their head.
An article written by Dr Edward Leatham, Consultant Cardiologist Tags: BP, CGM, Glucose, Telehealth, Homecare, NH1 search website using Tags to find related stories. Over the past decade, healthcare has experienced a remarkable evolution in how patients are monitored and managed […]
Annual health screenings are a valuable investment in employee well-being, offering significant benefits for both employees and employers. The HMRC’s tax exemption makes these screenings financially attractive, allowing companies to offer meaningful health benefits cost-effectively. Advanced medical technologies, such as AI-driven CT scans, enhance early detection capabilities, providing further value.
The CaRi Heart Score leverages artificial intelligence and advanced imaging techniques to provide a more comprehensive assessment of coronary inflammation, even before non calcified and calcified plaque becomes detectable on CT.
Ultimately, the approach to cardiac CT screening is highly individualized, reflecting the diverse presentations and risk factors among patients. By employing a sophisticated pre-consultation process, cardiologists can tailor their assessment and management plans to best suit each patient's unique needs, enhancing the precision and effectiveness of cardiac care.
Since 2016, cardiologists have been utilising the HeartFlow Analysis in conjunction with cardiac CT scans to enhance the accuracy and predictive value of noninvasive coronary imaging. This technology allows many patients to avoid unnecessary invasive angiography, reducing the associated risks and stress.
As we begin 2024, I want to highlight three groundbreaking developments from 2023 that promise a brighter future for healthcare, two of which leverage the power of artificial intelligence (AI).